top-selling glp-1 medications in the u.s. 2025 Trends: Costs & Coverage Barrier Amid Uncertainty GLP-1 boom makes Eli Lilly

Springer, Berlin Bosoi CR, Rose CF (2009) Identifying the direct effects of ammonia on the brain

In January 2025, the firm published results of a Phase 2 trial for VK2735 with strong potential, including up to nearly 15% of baseline body weight lost in trial participants without a clear plateau

Wintner, O., Hirsch-Attas, N., Schlossberg, M., Brofman, F., Friedman, R., Kupervaser, M., et al

BPC-157 & TB-500 CAPSULE SET: This research set combines BPC-157 (250mcg per capsule) and TB-500 (500mcg per capsule), two synthetic peptides studied for their roles in angiogenesis, actin regulation, tissue remodeling, and cellular signaling